Wall Street expects a year-over-year decline in earnings on lower revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended December 2024. While this widely-known consensus ...

The board of Sage Therapeutics unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company. That's not surprising – Sage filed a ...

Sage Therapeutics rejected a takeover offer from Biogen (BIIB) and said it started a process to review its strategic alternatives. Sage rose 5.6%. Diversified Energy (OTCQX:DEC) +2.6% pre-market ...

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30 ...

SaSPinjara Life Sciences, a technical and business consultation provider ... Giving an analytical overview of Indian pharma backed by analysis on the approvals granted by the National Medical Products ...

In Baghdad, Ibn Sina (Avicenna) writes the Canon of Medicine, a five-volume work encompassing all known medical knowledge ... sometimes referred to as the “science of the ancients.” ...

Our documentary studio works with some of the world’s best science filmmakers to craft powerful stories of scientific discovery. HHMI is a biomedical research organization and philanthropy that ...